The Role of Biomarkers to Diagnose Diabetic Foot Osteomyelitis. A Meta-analysis
Suzanne Aura Victoria van Asten1, Edgar Joseph Geradus Peters, Yin Xi
1Department of Plastic Surgery, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, Texas, USA. suzanne.vanasten@utsouthwestern.edu.
Purpose:
To systematically review the value of serum inflammatory markers to diagnose diabetic foot osteomyelitis (DFO).
Study Selection:
Studies to diagnose DFO using biomarkers erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), procalcitonin (PCT), interleukins (IL-2, IL-6, IL-8) and tumor necrosis factor alfa (TNF.) were retrieved from EMBASE and PubMed with no language restrictions through July 2014.
Data Extraction:
We summarized clinical characteristics of the studies and used bivariate random effects models and summary receiver operating characteristic curves to estimate sensitivity and specificity for each marker.
Data Synthesis:
A total of 8 qualifying studies were included in our meta-analysis. Bivariate pooled sensitivity and specificity of the 6 studies examining ESR were 0.81 (95% CI 0.71-0.88) and 0.90 (95% CI 0.75-0.96) respectively. Due to the paucity of data, models did not converge for the other biomarkers.
Conclusions:
From the inflammatory markers, ESR appears to be the best laboratory test to identify patients with DFO.
More Related Videos
09:15Come to the Light Side: In Vivo Monitoring of Pseudomonas aeruginosa Biofilm Infections in Chronic Wounds in a Diabetic Hairless Murine Model
Published on: October 10, 2017
04:09Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023